Corporate Profile
WuXi PharmaTech (pronounced woo-shee pharma-tek) is a leading global contract R&D services provider serving the pharmaceutical, biotech, and medical device industries. The company is headquartered in Shanghai and has operations in both China and the United States. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the R&D process. Our services are designed to help our global partners shorten the time and lower the cost of R&D. The parent company is known as WuXi PharmaTech, and its operating divisions are known as WuXi AppTec (pronounced woo-shee app-tek)... More >>
What's New
download pdf  Investor Fact Sheet
Recent NewsMore >>
DateTitle 
03/27/15Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA
SHANGHAI, March 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, announced today that an Investigational New Drug (IND) application for WuXi MedImmune's novel anti-IL6 monoclonal antibody for rheumatoid arthritis has been accepted for review by the China Food and Drug Administration (CFDA).  In September 2012, MedImmune, t... 
Printer Friendly Version
03/25/15Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide
Clinicians, researchers and population genomics programs around the world can build on this unique national effort to use the genome to better prevent, diagnose and treat disease SHANGHAI, CAMBRIDGE, Massachusetts, and REYKJAVIK, 25 March 2015 – WuXi NextCODE, which provides comprehensive capabilities for using the genome to create better medicine, today congratulated the scientists at deCODE genetics on their publication of the largest studies of whole-genome data yet undertaken. The studies ... 
Printer Friendly Version
03/12/15WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer Immunotherapies
SHANGHAI, March 12, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, announced today that it will soon begin construction of a new, 145,000-square-foot cGMP facility in Philadelphia for the manufacture of cell therapy products. This facility is designed for cell therapy products that contain viral vectors such as chimeric antigen recepto... 
Printer Friendly Version
03/05/15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results
SHANGHAI, March 5, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the fourth quarter and full year of 2014.  Fourth-Quarter 2014 Highlights Net Revenues Increased 21.3% Year Over Year to $190.6 Million Laboratory Services Net Revenues Gr... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Stock QuoteMore >>
WX (Common Stock)
ExchangeNYSE (US Dollar)
Price$37.64
Change (%) Stock is Up 0.36 (0.97%)
Volume251,407
Data as of 03/27/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
CalendarMore >>
March 2015?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
1234567
891011121314
15161718192021
22232425262728
29303151525354
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever WuXi PharmaTech (Cayman) Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.